Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cervical cancer and HPV infection: ongoing therapeutic research to counteract the action of E6 and E7 oncoproteins
Ana M. Almeida, João A. Queiroz, Fani Sousa, et al.
Drug Discovery Today (2019) Vol. 24, Iss. 10, pp. 2044-2057
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Advances in nucleic acid-based cancer vaccines
Hung‐Chun Liao, Shih‐Jen Liu
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 5
<p>Therapeutic Vaccines for HPV-Associated Malignancies</p>
Claire Smalley, Nicholas Roller, Samuel T. Pellom, et al.
ImmunoTargets and Therapy (2020) Vol. Volume 9, pp. 167-200
Open Access | Times Cited: 96
Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human Disease
Martijn P. T. Ernst, Mike Broeders, Pablo Herrero-Hernandez, et al.
Molecular Therapy — Methods & Clinical Development (2020) Vol. 18, pp. 532-557
Open Access | Times Cited: 81
Methods to improve the immunogenicity of plasmid DNA vaccines
Dalinda Eusébio, Ana R. Neves, Diana Costa, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 11, pp. 2575-2592
Closed Access | Times Cited: 70
The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)
Fatemeh Movahed, Satinik Darzi, Parya Mahdavi, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 13
NCAPH, ubiquitinated by TRIM21, promotes cell proliferation by inhibiting autophagy of cervical cancer through AKT/mTOR dependent signaling
Shiqi Wang, Xiaowen Qiao, Yaqi Cui, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 10
Precision therapeutic targets for HPV-positive cancers: an overview and new insights
Yaw‐Bin Huang, Jiayi Wang, Wenbin Yang, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Flavonoids-Based Delivery Systems towards Cancer Therapies
Miguel Ferreira, Diana Costa, Ângela Sousa
Bioengineering (2022) Vol. 9, Iss. 5, pp. 197-197
Open Access | Times Cited: 30
Development and Characterization of Quercetin-Loaded Delivery Systems for Increasing Its Bioavailability in Cervical Cancer Cells
Miguel Ferreira, Diana Gomes, Miguel Neto, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 936-936
Open Access | Times Cited: 17
Therapeutic effects and molecular mechanisms of quercetin in gynecological disorders
Xian Jian, Shi Chen, Weichen Luo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116418-116418
Open Access | Times Cited: 8
Resveratrol inhibits the progression of cervical cancer by suppressing the transcription and expression of HPV E6 and E7 genes
Xiaodong Sun, Pan Fu, Lixia Xie, et al.
International Journal of Molecular Medicine (2020) Vol. 47, Iss. 1, pp. 335-345
Open Access | Times Cited: 48
Quantitative proteomics reveals a broad‐spectrum antiviral property of ivermectin, benefiting for COVID‐19 treatment
Na Li, Lingfeng Zhao, Xianquan Zhan
Journal of Cellular Physiology (2020) Vol. 236, Iss. 4, pp. 2959-2975
Open Access | Times Cited: 47
Novel strategies in HPV‑16‑related cervical cancer treatment: An in vitro study of combined siRNA-E5 with oxaliplatin and ifosfamide chemotherapy
Reyhaneh Rasizadeh, Parisa Shiri Aghbash, Ahad Mokhtarzadeh, et al.
Gene (2024) Vol. 932, pp. 148904-148904
Closed Access | Times Cited: 6
RETRACTED: Development of novel HPV therapeutic vaccine constructs based on engineered exosomes and tumor cell lysates
Fatemeh Rezaei, Azam Bolhassani, Seyed Mehdi Sadat, et al.
Life Sciences (2024) Vol. 340, pp. 122456-122456
Closed Access | Times Cited: 5
Predictive modeling and web-based tool for cervical cancer risk assessment: A comparative study of machine learning models
Ritu Chauhan, Anika Goel, Bhavya Alankar, et al.
MethodsX (2024) Vol. 12, pp. 102653-102653
Open Access | Times Cited: 5
The roles of microRNA in human cervical cancer
Jingnan Miao, Joe M. Regenstein, Dan Xu, et al.
Archives of Biochemistry and Biophysics (2020) Vol. 690, pp. 108480-108480
Closed Access | Times Cited: 38
In Silico Approaches: A Way to Unveil Novel Therapeutic Drugs for Cervical Cancer Management
Diana Gomes, Samuel Silvestre, Ana Paula Duarte, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 8, pp. 741-741
Open Access | Times Cited: 30
Brucine promotes apoptosis in cervical cancer cells (ME‐180) via suppression of inflammation and cell proliferation by regulating PI3K/AKT/mTOR signaling pathway
Vidya Devanathadesikan Seshadri
Environmental Toxicology (2021) Vol. 36, Iss. 9, pp. 1841-1847
Closed Access | Times Cited: 29
Current Updates on Cancer-Causing Types of Human Papillomaviruses (HPVs) in East, Southeast, and South Asia
Chichao Xia, Sile Li, Teng Long, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2691-2691
Open Access | Times Cited: 28
siRNA-E6 sensitizes HPV-16-related cervical cancer through Oxaliplatin: an in vitro study on anti-cancer combination therapy
Parisa Shiri Aghbash, Nima Hemmat, Behzad Baradaran, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 12
Production of recombinant HPV11/16 E6/E7-MBP-His6 fusion proteins and their potential to induce cytokine secretion by immune cells in peripheral blood
Meinian Xu, Mei-zhen Zhong, Si-ning Feng, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Extracellular vesicular Wnt7b mediates HPV E6-induced cervical cancer angiogenesis by activating the β-catenin signaling pathway
Junjun Qiu, Shu-Gen Sun, Xiaoyan Tang, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 28
The Expression of Programmed Cell Death Ligand-1 and its Relationship with Infiltration, Metastasis and Prognosis in Cervical Squamous Cell Carcinoma
Juyan Ge, Xiujuan Xu
Reproductive Sciences (2025)
Closed Access
Investigating new drugs from marine seaweed metabolites for cervical cancer therapy by molecular dynamic modeling approach
Sk Injamamul Islam, Sheikh Sunzid Ahmed, Sarower Mahfuj, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Unraveling HPV-Associated cancer complexity: From molecular insights to innovative therapies
Tara Chand, Ashwini Kumar Dubey, Gauri Misra
Heliyon (2025) Vol. 11, Iss. 3, pp. e42437-e42437
Open Access
Page 1 - Next Page

Scroll to top